Tracking motherhood with a rare muscle disease

NCT ID NCT00567073

Recruiting now Knowledge-focused Sponsor: Genzyme, a Sanofi Company Source: ClinicalTrials.gov ↗

Summary

This study aims to collect information about pregnancy and infant development for women with Pompe disease, a rare genetic disorder. It will follow women who are pregnant, whether they are receiving standard enzyme replacement therapy or not, and track their babies' growth for three years after birth. No experimental treatments are given; researchers are simply observing outcomes to better understand how the disease affects pregnancy.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Barrow Neurol Group- Site Number : 840087
RECRUITING

Phoenix, Arizona, 85013, United States
Duke University Medical Center Genetics Dept- Site Number : 840037
RECRUITING

Durham, North Carolina, 27710, United States
Emory University School Of Medicine- Site Number : 840060
RECRUITING

Atlanta, Georgia, 30322, United States
Indianapolis University School of Medicine- Site Number : 840027
RECRUITING

Indianapolis, Indiana, 46202, United States
Investigational Site Number : 056001
RECRUITING

Ghent, 9000, Belgium
Investigational Site Number : 1910001
RECRUITING

Zagreb, 10000, Croatia
Investigational Site Number : 1910002
RECRUITING

Zagreb, 10000, Croatia
Investigational Site Number : 2030001
RECRUITING

Prague, 12808, Czechia
Investigational Site Number : 380002
RECRUITING

Padua, 35128, Italy
Investigational Site Number : 380003
RECRUITING

Pavia, 27100, Italy
Investigational Site Number : 380004
RECRUITING

Genova, 16147, Italy
Investigational Site Number : 380005
RECRUITING

Florence, 50141, Italy
Investigational Site Number : 380006
RECRUITING

Cagliari, 09126, Italy
Investigational Site Number : 380007
RECRUITING

Milan, 20133, Italy
Investigational Site Number : 380008
RECRUITING

Brescia, 25123, Italy
Investigational Site Number : 380009
RECRUITING

Monza, Italy
Investigational Site Number : 380011
RECRUITING

Padua, 35128, Italy
Investigational Site Number : 380012
RECRUITING

Roma, Italy
Investigational Site Number : 380013
RECRUITING

Messina, 98125, Italy
Investigational Site Number : 380015
RECRUITING

Roma, 00165, Italy
LSD Data Registry Site LLC- Site Number : 840094
RECRUITING

Dublin, Ohio, 43017, United States
Mt. Sinai School of Medicine- Site Number : 840005
RECRUITING

New York, New York, 10029, United States
New York University School Of Medicine- Site Number : 840040
RECRUITING

New York, New York, 10016, United States
O&O Alpan, LLC- Site Number : 840025
RECRUITING

Fairfax, Virginia, 22030, United States
Oregon Health and Science University- Site Number : 840095
COMPLETED

Portland, Oregon, 97239, United States
Spectrum for Health- Site Number : 840019
RECRUITING

Grand Rapids, Michigan, 49503, United States

Conditions

Explore the condition pages connected to this study.

GLYCOGEN STORAGE DISEASE TYPE II (GSD-II) GLYCOGENESIS 2 ACID MALTASE DEFICIENCY POMPE DISEASE (LATE-ONSET)